The DOI matches its Crossref record.
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
Open accessAbstract
1,25-Dihydroxyvitamin D (1,25-(OH)2D3) directly suppresses the secretion and synthesis of PTH in vivo and in cell culture. This compound has been used to treat secondary hyperparathyroidism associated with renal failure, but in some patients prolonged treatment with 1,25-(OH)2D3 results in hypercalcemia. An analogue of 1,25-(OH)2D3 with little or no calcemic activity, 22-oxacalcitriol (OCT), was recently developed. We confirmed this lack of calcemic activity by acute and chronic administration to normal rats. A single intraperitoneal injection of vehicle (propylene glycol), OCT, or 1,25-(OH)2D3 (1.0 micrograms/rat) increased calcium by 0.32, 0.30, and 1.40 mg/dl, respectively. When rats were given daily injections of vehicle or 0.5 micrograms of either 1,25-(OH)2D3 or OCT for 4 d, calcium did not change in the rats receiving vehicle or OCT, but increased from 8.4 to 11.4 mg/dl in the rats treated with 1,25-(OH)2D3. In primary cultures of bovine parathyroid cells, 10 nM OCT was as active as 10 nM 1,25-(OH)2D3, suppressing PTH release by 33%. This suppression is due, at least in part, to blocking of transcription of the PTH gene. Using a probe prepared by random prime labeling of an Msp I fragment of plasmid PTHm122, we found that a single 40-ng dose of OCT or 1,25-(OH)2D3 depressed PTH mRNA levels by 70-80% by 48 h when compared with vehicle. Thus, OCT is a very effective suppressor of PTH secretion with virtually no calcemic activity. This analogue may be a valuable tool for the treatment of secondary hyperparathyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J.-C., Thompson, P. D., Selznick, S. H., Dominguez, C. E., & Jurutka, P. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.325 · Cited by 1,421
Structure-Function Relationships in the Vitamin D Endocrine System*
BOUILLON, R., OKAMURA, W. H., & NORMAN, A. W. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-200 · Cited by 1,235
Dusso, A. S., Brown, A. J., & Slatopolsky, E. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00336.2004 · Cited by 1,148
Self-citationThe Pathogenesis and Treatment of Kidney Stones
Coe, F. L., Parks, J. H., & Asplin, J. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271607 · Cited by 696
Renal bone disease 1990: An unmet challenge for the nephrologist
Malluche, H., & Faugere, M.-C. (1990) · Kidney International · doi:10.1038/ki.1990.187 · Cited by 362
Metadata
- Authors
- Brown, A. J., Ritter, C. R., Finch, J. L., Morrissey, J., Martin, K. J., Murayama, E., Nishii, Y., & Slatopolsky, E.
- Venue
- Journal of Clinical Investigation
- Published
- 1989-09-01
- Volume
- 84
- Issue
- 3
- Pages
- 728-732
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W3028210632
- Cited by
- 236
- References
- 0
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. https://app.cochat.ai/papers/10.1172/jci114229
- The paper
- Brown, A. J., Ritter, C. R., Finch, J. L., Morrissey, J., Martin, K. J., Murayama, E., Nishii, Y., & Slatopolsky, E. (1989). The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. Journal of Clinical Investigation. https://doi.org/10.1172/jci114229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.